High cholesterol can heighten the risk of serious health issues, with the condition having some unusual symptoms ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Optician Tina Patel highlighted the subtle yet alarming signs of sky-high cholesterol that might be visible on one's eyelids.

Considering taking supplements to treat retinal vein occlusion? Below is a list of common natural remedies used to treat or reduce the symptoms of retinal vein occlusion. Follow the links to read ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.

Regeneron (REGN) announces FDA review of sBLA for Eylea HD to treat macular edema and expand dosing. Read more here.